{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:21:10Z","timestamp":1774340470906,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI103044"],"award-info":[{"award-number":["K23AI103044"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI122001"],"award-info":[{"award-number":["R21AI122001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW007124"],"award-info":[{"award-number":["D43TW007124"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008801","name":"Atlanta Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["UL1TR000454"],"award-info":[{"award-number":["UL1TR000454"]}],"id":[{"id":"10.13039\/100008801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/jac\/dkx421","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T23:12:42Z","timestamp":1508541162000},"page":"477-483","source":"Crossref","is-referenced-by-count":22,"title":["Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study"],"prefix":"10.1093","volume":"73","author":[{"given":"M Tobias","family":"Heinrichs","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Florida, Gainesville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergo","family":"Vashakidze","sequence":"additional","affiliation":[{"name":"National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketino","family":"Nikolaishvili","sequence":"additional","affiliation":[{"name":"National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Sabulua","sequence":"additional","affiliation":[{"name":"National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nestani","family":"Tukvadze","sequence":"additional","affiliation":[{"name":"National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nino","family":"Bablishvili","sequence":"additional","affiliation":[{"name":"National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Gogishvili","sequence":"additional","affiliation":[{"name":"National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent P","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Radiology, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bernheim","sequence":"additional","affiliation":[{"name":"Department of Radiology, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Guarner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A","family":"Peloquin","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Florida, Gainesville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry M","family":"Blumberg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA"},{"name":"Departments of Epidemiology and Global Health, Emory Rollins School of Public Health, Emory University, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Derendorf","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Florida, Gainesville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell R","family":"Kempker","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"key\n\t\t\t\t20180328172554_dkx421-B1","volume-title":"Global Tuberculosis Report 2016 (WHO\/HTM\/TB\/2016.13)","author":"WHO","year":"2016"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B2","volume-title":"A Global Action Framework for TB Research: In Support of the Third Pillar of WHO\u2019s End TB Strategy (WHO\/HTM\/TB\/2015.26)","author":"WHO","year":"2015"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B3","doi-asserted-by":"crossref","first-page":"e1001965.","DOI":"10.1371\/journal.pmed.1001965","article-title":"Translational research for tuberculosis elimination: priorities, challenges, and actions","volume":"13","author":"Lienhardt","year":"2016","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciu619","article-title":"Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis","volume":"59","author":"Bastos","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.48.3.780-782.2004","article-title":"Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dku457","article-title":"Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents","volume":"70","author":"Lakshminarayana","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4155\/fmc.10.224","article-title":"In vitro pharmacokinetic\/pharmacodynamic models in anti-infective drug development: focus on TB","volume":"2","author":"Vaddady","year":"2010","journal-title":"Future Med Chem"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug\u2019","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B10","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ijantimicag.2010.11.011","article-title":"Pharmacokinetic\/pharmacodynamic (PK\/PD) considerations in the management of Gram-positive bacteraemia","volume":"36","author":"Scaglione","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3201\/eid2106.141873","article-title":"Acquired drug resistance in Mycobacterium tuberculosis and poor outcomes among patients with multidrug-resistant tuberculosis","volume":"21","author":"Kempker","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1208\/s12248-016-0020-1","article-title":"Utility of microdialysis in infectious disease drug development and dose optimization","volume":"19","author":"Deitchman","year":"2017","journal-title":"AAPS J"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40262-014-0131-8","article-title":"Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions","volume":"53","author":"Azeredo","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B14","doi-asserted-by":"crossref","first-page":"e00226-17.","DOI":"10.1128\/AAC.00226-17","article-title":"Lung tissue concentrations of pyrazinamide among patients with drug-resistant pulmonary tuberculosis","volume":"61","author":"Kempker","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B15","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.00379-15","article-title":"Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis","volume":"59","author":"Kempker","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B16","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/AAC.42.8.2060","article-title":"Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects","volume":"42","author":"Stass","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/AAC.42.7.1706","article-title":"Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits","volume":"42","author":"Ostergaard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B18","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"M\u00fcller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B19","author":"US FDA","year":"1998"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B20","author":"LaMorte WW"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","volume":"74","author":"Alsultan","year":"2014","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B22","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/AAC.44.10.2600-2603.2000","article-title":"Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers","volume":"44","author":"Lubasch","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.01036-07","article-title":"Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis","volume":"52","author":"Peloquin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/oxfordjournals.bmb.a072252","article-title":"Effect of anaesthesia and surgery on pharmacokinetics and pharmacodynamics","volume":"44","author":"Nimmo","year":"1988","journal-title":"Br Med Bull"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-199121040-00005","article-title":"Pharmacokinetic drug interactions in anaesthetic practice","volume":"21","author":"Wood","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B26","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/AAC.49.6.2429-2437.2005","article-title":"Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages","volume":"49","author":"Michot","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.athoracsur.2007.06.052","article-title":"In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery","volume":"84","author":"Hutschala","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4614-4815-0_2","volume-title":"Microdialysis in Drug Development","author":"de Lange","year":"2013"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.47.3.833-836.2003","article-title":"Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary","volume":"47","author":"Grosset","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1179\/joc.2003.15.6.558","article-title":"Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state","volume":"15","author":"Breilh","year":"2003","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/424849","article-title":"Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling","volume":"190","author":"Gumbo","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328172554_dkx421-B32","author":"National Kidney Foundation"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/2\/477\/24332614\/dkx421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T20:02:57Z","timestamp":1570219377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/2\/477\/4654831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx421","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,11,23]]}}}